# A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours

> **NCT03851146** · PHASE1 · COMPLETED · sponsor: **Peter MacCallum Cancer Centre, Australia** · enrollment: 20 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **BIOLOGICAL:** LeY CAR T cells

## Key facts

- **NCT ID:** NCT03851146
- **Lead sponsor:** Peter MacCallum Cancer Centre, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-24
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03851146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03851146, "A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03851146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*